Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (603896.SS) Dividend, Growth and Profitability Scores

Dividend

Growth

Last update : Jul 30, 2026

3F6iwVWk

Metrics

Value

Rating

Revenue growth82

G5fTi6TXwn

5Y Revenue growth52

fwiIX45bHv

EBITDA growth89

sQSjgSqFSG

5Y EBITDA growth88

uTRFurXBPe

Operating income growth20

FvhlqBKy9m

5Y Operating income growth36

F9DdFplECk

Free cash flow growth100

erqRNz6p7K

5Y Free cash flow growth77

Qyf2kPAF5f

Operating cash flow growth30

Nua61yT7Fe

5Y Operating cash flow growth66

hL2NCkF7oE

Capex growth83

pijC3jzQMz

Financial Strength

Last update : Jul 30, 2026

18G2LU

Metrics

Value

Rating

Interest coverage77

O7n1JDl2T9

Quick ratio10

s6hSM0TRg5

Debt / Assets3

Cjavd4lSsA

Profitability

Last update : Jul 30, 2026

18AzzPE

Metrics

Value

Rating

Gross margin76

KUWmpyR90u

Operating margin31

OlXKKul1vf

Net margin18

B9gHzBidOu

Momentum

Last update : Aug 16, 2026

19CCymdN1G

Metrics

ESG

No data available currently

Zhejiang Shouxiangu Pharmaceutical Co., Ltd.

603896.SS - CNE100002XJ4

Zhejiang Shouxiangu Pharmaceutical Co., Ltd.

603896.SS - CNE100002XJ4

Dividend

Growth

Financial Strength

Profitability

Momentum

ESG

Piotroski F

Unlock this feature

Altman Z

Unlock this feature

Image Modal

Zhejiang Shouxiangu Pharmaceutical Co., Ltd.

603896.SS - CNE100002XJ4

Image Modal

Zhejiang Shouxiangu Pharmaceutical Co., Ltd.

603896.SS - CNE100002XJ4

Dividend

Growth

Financial Strength

Profitability

Momentum

ESG

Piotroski F

Unlock this feature

Altman Z

Unlock this feature